应用IDEAL-IQ技术体内评估C型尼曼-匹克病的神经退行性变
本研究对12例C型尼曼-匹克病患者和20名健康对照行脑MRI、IDEAL-IQ及1H-MRS检查,发现患者T2高信号病灶及表现正常区域的脂肪/水信号强度比均高于健康对照,治疗后该比值下降但仍高于对照;IDEAL-IQ可检出1H-MRS未能显示的表现正常区域微量脂质沉积,提示其可能作为无创客观评估NPC的方法。
要点
- NPC患者T2高信号病灶的IDEAL-IQ脂肪/水信号强度比为3.7-4.9%,高于健康对照的1.2-2.3%。
- 患者表现正常区域的脂肪/水信号强度比为1.8-3.0%,亦高于健康对照,且1H-MRS未能检出该区域微量脂质沉积。
- 治疗后脂肪/水信号强度比降至2.2-3.4%,但仍高于健康对照。
核心结论
- 研究结果提示,IDEAL-IQ可能作为无创、客观的方法用于评估NPC患者,并可定量测量脑实质脂肪含量及监测治疗后随访。
研究设计与样本
- 对12例C型尼曼-匹克病患者(4男8女,年龄15-61岁,平均36岁)和20名健康受试者(10男10女,年龄20-65岁,平均38岁)行常规脑MRI、IDEAL-IQ及1H-MRS(作为对照)检查。
关键影像表现/征象
- NPC患者T2高信号病灶的IDEAL-IQ脂肪/水信号强度比为3.7-4.9%,健康对照为1.2-2.3%。
- NPC患者表现正常区域的脂肪/水信号强度比为1.8-3.0%,健康对照为1.2-2.3%。
- 1H-MRS显示相同病灶区域脂质峰升高,但表现正常区域的微量脂质沉积仅IDEAL-IQ可检出,1H-MRS未能检出。
诊断标准与关键数值
- IDEAL-IQ脂肪/水信号强度比:患者T2高信号病灶3.7-4.9%,表现正常区域1.8-3.0%,健康对照1.2-2.3%。
- 治疗后患者脂肪/水信号强度比为2.2-3.4%,仍高于健康对照。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To noninvasively assess the neurodegenerative changes in the brain of patients with Niemann-Pick type C (NPC) disease by measuring the lesion tissue with the iterative decomposition of water and fat with echo asymmetry and least square estimation-iron quantification (IDEAL-IQ).
MATERIALS AND METHODS: Routine brain MRI, IDEAL-IQ and 1H-proton magnetic resonance spectroscopy (1H-MRS, served as control) were performed on 12 patients with type C Niemann-Pick disease (4 males and 8 females; age range, 15-61 years; mean age, 36 years) and 20 healthy subjects (10 males and 10 females; age range, 20-65 years; mean age, 38 years). The regions with lesion and the normal appearing regions (NARs) of patients were measured and analyzed based on the fat/water signal intensity on IDEAL-IQ and the lipid peak on 1H-MRS.
RESULTS: Niemann-Pick type C patients showed a higher fat/water signal intensity ratio with IDEAL-IQ on T2 hyperintensity lesions and NARs (3.7-4.9%, p < 0.05 and 1.8-3.0%, p < 0.05, respectively), as compared to healthy controls (HCs) (1.2-2.3%). After treatment, the fat/water signal intensity ratio decreased (2.2-3.4%), but remained higher than in the HCs (p < 0.05). The results of the 1H-MRS measurements showed increased lipid peaks in the same lesion regions, and the micro-lipid storage disorder of NARs in NPC patients was detectable by IDEAL-IQ instead of 1H-MRS.
CONCLUSION: The findings of this study suggested that IDEAL-IQ may be useful as a noninvasive and objective method in the evaluation of patients with NPC; additionally, IDEAL-IQ can be used to quantitatively measure the brain parenchymal adipose content and monitor patient follow-up after treatment of NPC.
引用
- Guo RM, Li QL, Luo ZX, et al. In Vivo Assessment of Neurodegeneration in Type C Niemann-Pick Disease by IDEAL-IQ. Korean J Radiol. 2018. PMID: 29354005. doi:10.3348/kjr.2018.19.1.93
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。